Domain-swapped structure of a mutant of cyanovirin-N

被引:23
作者
Botos, I
Mori, T
Cartner, LK
Boyd, MR
Wlodawer, A [1 ]
机构
[1] NCI, Macromol Crystallog Lab, Frederick, MD 21702 USA
[2] NCI, Ctr Canc Res, Mol Targets Drug Discovery Program, Frederick, MD 21702 USA
[3] NCI, Sci Applicat Int Corp, Frederick, MD 21702 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1016/S0006-291X(02)00455-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cyanovirin-N (CV-N) is a potent 11 kDa HIV-inactivating protein that binds with high affinity to the HIV surface envelope protein gp120. A double mutant P51S/S52P of CV-N was engineered by swapping two critical hinge-region residues Pro51 and Ser52. This mutant has biochemical and biophysical characteristics equivalent to the wild-type CV-N and its structure resembles that of wild-type CV-N. However, the mutant shows a different orientation in the hinge region that connects two domains of the protein. The observation that this double mutant crystallizes under a wide variety of conditions challenges some of the current hypotheses on domain swapping and on the role of hinge-region proline residues in domain orientation. The current structure contributes to the understanding of domain swapping in cyanovirins, permitting rational design of domain-swapped CV-N mutants. (C) 2002 Published by Elsevier Science (USA).
引用
收藏
页码:184 / 190
页数:7
相关论文
共 35 条
[1]   The domain-swapped dimer of cyanovirin-N is in a metastable folded state: Reconciliation of X-ray and NMR structures [J].
Barrientos, LG ;
Louis, JM ;
Botos, I ;
Mori, T ;
Han, ZZ ;
O'Keefe, BR ;
Boyd, MR ;
Wlodawer, A ;
Gronenborn, AM .
STRUCTURE, 2002, 10 (05) :673-686
[2]   REFINED STRUCTURE OF MONOMERIC DIPHTHERIA-TOXIN AT 2.3-ANGSTROM RESOLUTION [J].
BENNETT, MJ ;
EISENBERG, D .
PROTEIN SCIENCE, 1994, 3 (09) :1464-1475
[3]   3D DOMAIN SWAPPING - A MECHANISM FOR OLIGOMER ASSEMBLY [J].
BENNETT, MJ ;
SCHLUNEGGER, MP ;
EISENBERG, D .
PROTEIN SCIENCE, 1995, 4 (12) :2455-2468
[4]   Solution structure of cyanovirin-N, a potent HIV-inactivating protein [J].
Bewley, CA ;
Gustafson, KR ;
Boyd, MR ;
Covell, DG ;
Bax, A ;
Clore, GM ;
Gronenborn, AM .
NATURE STRUCTURAL BIOLOGY, 1998, 5 (07) :571-578
[5]   HIV-inhibitory natural products part 71 - Cyanovirin-N defines a new class of antiviral agent targeting N-linked, high-mannose glycans in an oligosaccharide-specific manner [J].
Bolmstedt, AJ ;
O'Keefe, BR ;
Shenoy, SR ;
Mcmahon, JB ;
Boyd, MR .
MOLECULAR PHARMACOLOGY, 2001, 59 (05) :949-954
[6]   Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: Potential applications to microbicide development [J].
Boyd, MR ;
Gustafson, KR ;
McMahon, JB ;
Shoemaker, RH ;
OKeefe, BR ;
Mori, T ;
Gulakowski, RJ ;
Wu, L ;
Rivera, MI ;
Laurencot, CM ;
Currens, MJ ;
Cardellina, JH ;
Buckheit, RW ;
Nara, PL ;
Pannell, LK ;
Sowder, RC ;
Henderson, LE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (07) :1521-1530
[7]   FREE R-VALUE - A NOVEL STATISTICAL QUANTITY FOR ASSESSING THE ACCURACY OF CRYSTAL-STRUCTURES [J].
BRUNGER, AT .
NATURE, 1992, 355 (6359) :472-475
[8]   SLOW-COOLING PROTOCOLS FOR CRYSTALLOGRAPHIC REFINEMENT BY SIMULATED ANNEALING [J].
BRUNGER, AT ;
KRUKOWSKI, A ;
ERICKSON, JW .
ACTA CRYSTALLOGRAPHICA SECTION A, 1990, 46 :585-593
[9]   Crystallography & NMR system:: A new software suite for macromolecular structure determination [J].
Brunger, AT ;
Adams, PD ;
Clore, GM ;
DeLano, WL ;
Gros, P ;
Grosse-Kunstleve, RW ;
Jiang, JS ;
Kuszewski, J ;
Nilges, M ;
Pannu, NS ;
Read, RJ ;
Rice, LM ;
Simonson, T ;
Warren, GL .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1998, 54 :905-921
[10]   ALIGN: a program to superimpose protein coordinates, accounting for insertions and deletions [J].
Cohen, GH .
JOURNAL OF APPLIED CRYSTALLOGRAPHY, 1997, 30 :1160-1161